Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

18 The Company Das Unternehmen
ELVeS The future is radial
Venous reflux disease is a common condition affecting more than 8 million people in Germany and
more than 30 million in the US. Since its market launch the ELVeS (Endo Laser Vein System) treatment
has established itself worldwide as the minimally invasive concept of choice for treating varicose veins
and has set a new standard by minimizing after-effects in a non-traumatizing way.
Continuously striving to improve our ELVeS treatment concept to establish a new benchmark for patient
and users has lead to the development of ELVeS PainLess and the new ELVeS RADIAL Fiber.
ELVeS PainLess is a versatile and easy to use system allowing for minimally invasive treatment of varicose
veins with significantly reduced post-operative pain, excellent medical and cosmetic results and
high patient satisfaction.
The new ELVeS RADIAL Fiber will change the future of endovenous laser treatment radically. The patented
ELVeS RADIAL fiber is the first radial emitting laser fiber worldwide used for endovenous laser
treatments of the greater saphenous vein / smaller saphenous vein in patients with superficial vein reflux.
The procedure can be performed without tumescence eliminating cosmetically undesirable injection
marks and providing substantial time savings. The ELVeS RADIAL fiber applies the energy faster and
more targeted than any other available fiber in the endovenous market. It guarantees safe closure of the
vein and eliminates perforation and charring due to its homogenous circumferential (360°) energy
emission.
The newly developed Slim-RADIAL-fiber is particularly suitable for the treatment of more convoluted
blood vessels and arterial side branches.